{"id":89,"date":"2023-10-19T15:47:27","date_gmt":"2023-10-19T19:47:27","guid":{"rendered":"https:\/\/ar.bu.edu\/2023\/?page_id=89"},"modified":"2023-12-05T01:28:30","modified_gmt":"2023-12-05T06:28:30","slug":"pathogen-busters","status":"publish","type":"page","link":"https:\/\/ar.bu.edu\/2023\/pathogen-busters\/","title":{"rendered":"Pathogen Busters"},"content":{"rendered":"<figure id=\"attachment_396\" aria-describedby=\"caption-attachment-396\" style=\"width: 487px\" class=\"wp-caption alignright\"><img loading=\"lazy\" src=\"\/2023\/files\/2023\/10\/23-1434-AR1-001-477x636.jpg\" alt=\"Elke Muhlberger, a professor in Microbiology &amp; Director in Integrated Science Core poses sitting down in a room where lab techs switch out protective full-body suits. She looks exasperated, but hopeful. Photo by Doug Levy for Boston University Photography.\" width=\"477\" height=\"636\" class=\"size-medium wp-image-396\" srcset=\"https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-477x636.jpg 477w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-768x1024.jpg 768w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-1152x1536.jpg 1152w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-1536x2048.jpg 1536w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-500x667.jpg 500w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-1000x1334.jpg 1000w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/23-1434-AR1-001-scaled.jpg 1921w\" sizes=\"(max-width: 477px) 100vw, 477px\" \/><figcaption id=\"caption-attachment-396\" class=\"wp-caption-text\">Elke M\u00fchlberger<\/figcaption><\/figure>\n<h3 class=\"p1\">HOW TO GO ANTIVIRAL<\/h3>\n<p class=\"p1\"><span class=\"s1\"><b>The next pandemic could be lurking, ready to strike, and Boston University researchers aren\u2019t waiting to find out.<\/b><\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">In early 2023, six of our scientists joined <a href=\"https:\/\/www.bu.edu\/articles\/2023\/bu-researchers-join-100-million-effort-to-fight-future-deadly-pathogens\/\">a $100 million effort to advance the understanding of dangerous pathogens<\/a>\u2014and help spur new ways to defeat or at least contain them.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\"> The <b>HOWARD HUGHES MEDICAL INSTITUTE&#8217;S (HHMI) EMERGING PATHOGENS INITIATIVE<\/b> is pulling in 70 scientists from 29 organizations who will be part of teams working on the next generation of RNA-based antiviral therapies. BU\u2019s share of the funding will be <b>$10.75 MILLION<\/b>.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">Among those contributing to the HHMI initiative is <a href=\"https:\/\/www.bumc.bu.edu\/virol-immunol-microbio\/people\/faculty\/elke-muhlberger-phd\/\"><b>ELKE M\u00dcHLBERGER<\/b><\/a>, director of integrated science services at BU\u2019s <a href=\"https:\/\/www.bu.edu\/neidl\/\"><b>NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES<\/b><\/a><b> <\/b>(NEIDL). NEIDL is a state-of-the-art research facility that focuses on infectious diseases that are\u2014or can become\u2014public health threats. M\u00fchlberger is a professor of microbiology and an expert on highly pathogenic viruses like Ebola, Marburg, and SARS-CoV-2. She recently started investigating other viruses of concern, including Nipah\u2014a bat-borne disease with the potential to infect humans\u2014that is high on the World Health Organization\u2019s priority list for research.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\"> M\u00fchlberger is teaming up with BU colleagues, biochemist <a href=\"https:\/\/www.bumc.bu.edu\/biochemcellbio\/profiles\/daniel-cifuentes\/\"><b>DANIEL CIFUENTES<\/b><\/a><b> <\/b>and\u00a0microbiologist <a href=\"https:\/\/www.bumc.bu.edu\/virol-immunol-microbio\/people\/faculty\/anthony-griffiths-ph-d\/\"><b>ANTHONY GRIFFITHS<\/b><\/a>. M\u00fchlberger says, \u201cThe goal is to come up with mechanisms and strategies, to use the knowledge that we gain through this project to block these viruses, to find antiviral countermeasures.\u201d<\/span><\/p>\n<figure id=\"attachment_384\" aria-describedby=\"caption-attachment-384\" style=\"width: 646px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" src=\"\/2023\/files\/2023\/10\/21-1419-SUDER-022-636x424.jpg\" alt=\"A scientist named Ellen Suder preps her suit before working in the high containment lab, BSL-4, at the NEIDL. Photo by Cydney Scott for Boston University Photography.\" class=\"size-medium wp-image-384\" width=\"636\" height=\"424\" srcset=\"https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/21-1419-SUDER-022-636x424.jpg 636w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/21-1419-SUDER-022-1024x683.jpg 1024w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/21-1419-SUDER-022-768x512.jpg 768w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/21-1419-SUDER-022-1536x1024.jpg 1536w, https:\/\/ar.bu.edu\/2023\/files\/2023\/10\/21-1419-SUDER-022-2048x1365.jpg 2048w\" sizes=\"(max-width: 636px) 100vw, 636px\" \/><figcaption id=\"caption-attachment-384\" class=\"wp-caption-text\">BU researcher Ellen Suder preps her suit for work in the BSL-4 high containment lab at the NEIDL.<\/figcaption><\/figure>\n<blockquote>\n<p class=\"p1\">The goal is to come up with mechanisms and strategies\u2026to block these viruses, to find antiviral countermeasures.<\/p>\n<\/blockquote>\n<p>\u2014 Elke M\u00fchlberger, Director of Integrated Science Services at NEIDL<\/p>\n<p class=\"p2\"><span class=\"s1\">The other <b>EMERGING PATHOGENS INITIATIVE<\/b> team featuring BU researchers includes <b><a href=\"https:\/\/www.bu.edu\/dental\/profile\/ruslan-afasizhev\/\">RUSLAN AFASIZHEV<\/a>, <a href=\"https:\/\/www.bu.edu\/dental\/profile\/inna-afasizheva\/\">INNA AFASIZHEVA<\/a><\/b>, and <a href=\"https:\/\/www.bumc.bu.edu\/camed\/profile\/john-samuelson\/\"><b>JOHN SAMUELSON<\/b><\/a>, all BU Henry M. Goldman School of Dental Medicine molecular and cell biology faculty members. They are working with scientists from the Broad Institute, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital to decode key proteins\u2014known as mitochondrial proteomes\u2014in six disease-causing parasites. <\/span><\/p>\n<p class=\"p2\"><span class=\"s2\">Afasizhev says that the work could also lay the foundation for developing a new generation of drugs targeting historically neglected diseases. \u201cWe aim to build highly accurate and comprehensive mitochondrial proteomes of parasites that cause human diseases in some of the most disadvantaged countries in the world.\u201d<\/span><span class=\"s1\"> <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>HOW TO GO ANTIVIRAL The next pandemic could be lurking, ready to strike, and Boston [&hellip;]<\/p>\n","protected":false},"author":12906,"featured_media":0,"parent":0,"menu_order":9,"comment_status":"closed","ping_status":"closed","template":"bu-landing","meta":[],"_links":{"self":[{"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/pages\/89"}],"collection":[{"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/users\/12906"}],"replies":[{"embeddable":true,"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/comments?post=89"}],"version-history":[{"count":26,"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/pages\/89\/revisions"}],"predecessor-version":[{"id":702,"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/pages\/89\/revisions\/702"}],"wp:attachment":[{"href":"https:\/\/ar.bu.edu\/2023\/wp-json\/wp\/v2\/media?parent=89"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}